Pages that link to "Q38169341"

The following pages link to Purinergic receptor P2X₇: a novel target for anti-inflammatory therapy (Q38169341):

Displaying 28 items.

• Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease (Q26741037) (← links)
• P2X ion channel receptors and inflammation (Q28066934) (← links)
• The role of pannexin1 in the induction and resolution of inflammation (Q30405747) (← links)
• Resveratrol-decreased hyperalgesia mediated by the P2X7 receptor in gp120-treated rats (Q33752131) (← links)
• P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation (Q35234523) (← links)
• Medicinal chemistry of adenosine, P2Y and P2X receptors (Q35873582) (← links)
• LncRNA NONRATT021972 involved the pathophysiologic processes mediated by P2X7 receptors in stellate ganglia after myocardial ischemic injury (Q36568412) (← links)
• Ion channels in innate and adaptive immunity (Q36769825) (← links)
• LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia. (Q36828020) (← links)
• Nucleoside-Diphosphate-Kinase of P. gingivalis is Secreted from Epithelial Cells In the Absence of a Leader Sequence Through a Pannexin-1 Interactome. (Q37435304) (← links)
• Redox distress and genetic defects conspire in systemic autoinflammatory diseases (Q38560502) (← links)
• Inflammasome activators induce fibronectin expression and release in macrophages (Q38729866) (← links)
• The microglial ATP-gated ion channel P2X7 as a CNS drug target (Q38843107) (← links)
• Challenges to develop novel anti-inflammatory and analgesic drugs (Q38941483) (← links)
• Cisplatin activates volume-sensitive like chloride channels via purinergic receptor pathways in nasopharyngeal carcinoma cells (Q38955222) (← links)
• Purinergic receptors: new targets for the treatment of gout and fibrosis (Q39019348) (← links)
• Structural insights into the competitive inhibition of the ATP-gated P2X receptor channel (Q42376006) (← links)
• Effects of LncRNA BC168687 siRNA on Diabetic Neuropathic Pain Mediated by P2X7 Receptor on SGCs in DRG of Rats. (Q47147359) (← links)
• The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression (Q47571865) (← links)
• The P2X7 Receptor in Inflammatory Diseases: Angel or Demon? (Q50202418) (← links)
• Antagonists of the P2X7 receptor: mechanism of enantioselective recognition using highly sulfated and sulfobutylether cyclodextrins by capillary electrokinetic chromatography (Q51083885) (← links)
• P2X7 Receptor Expression in Peripheral Blood Monocytes Is Correlated With Plasma C-Reactive Protein and Cytokine Levels in Patients With Type 2 Diabetes Mellitus: a Preliminary Report. (Q53841115) (← links)
• Andrographolide Inhibits Mechanical and Thermal Hyperalgesia in a Rat Model of HIV-Induced Neuropathic Pain. (Q55285468) (← links)
• ATP/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols (Q58701377) (← links)
• Spinal P2X7R contributes to streptozotocin-induced mechanical allodynia in mice (Q89961856) (← links)
• P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming? (Q90016514) (← links)
• IL-1β expression is increased and regulates GABA transmission following chronic ethanol in mouse central amygdala (Q91811672) (← links)
• Design, synthesis, and in vitro evaluation of novel P2X7 antagonists (Q99610757) (← links)